Atreca

About:

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Website: http://www.atreca.com

Top Investors: Mission BioCapital, Bill & Melinda Gates Foundation, Samsara BioCapital, Cormorant Asset Management, Wellington Management

Description:

Atreca is a biopharmaceutical that develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. Its product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.